Rachel Vaknin - Feb 22, 2024 Form 4 Insider Report for Microbot Medical Inc. (MBOT)

Signature
/s/ Rachel Vaknin
Stock symbol
MBOT
Transactions as of
Feb 22, 2024
Transactions value $
$0
Form type
4
Date filed
2/26/2024, 06:41 PM
Previous filing
Aug 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBOT Stock Option (Right to Buy) Award $0 +17.5K $0.00 17.5K Feb 22, 2024 Common Stock, par value $0.01 per share 17.5K $1.27 Direct F1
transaction MBOT Stock Option (Right to Buy) Award $0 +17.5K $0.00 17.5K Feb 22, 2024 Common Stock, par value $0.01 per share 17.5K $1.27 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.